Centinel Spine completed the acquisition of the worldwide assets of prodisc total disc replacement.
Here are five things to know:
1. Centinel Spine acquired DePuy Synthes Products' prodisc total disc replacement portfolio, including:
● Prodisc C
● Prodisc L
● Prodisc Vivo
● Prodisc Nova
● Prodisc O
● Discover Cervical
2. The acquired portfolio will support Centinel's standalone product portfolio. The company has a 30 year history of developing integrated devices into standard treatment for degenerative disc disease.
3. Centinel plans to apply its clinical, regulatory and development expertise to expand acceptance and increase insurance carrier coverage as well as surgeon adoption of total disc replacement worldwide.
4. The company has a history with prodisc; Centinel's lead investor, Viscogliosi Brothers, led the original IDE study to bring prodisc to the U.S.
5. In tandem with the acquisition, Centinel Spine completed debt and equity financing to close the transaction and provide working capital, with Piper Jaffray & Co. as the sale placement agent for Centinel Spine.